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Abstract
Objective. Investigate which individual characteristics inuenced the uptake of the
2009 H1N1 vaccination in England. The vaccination was provided for free to a specied
target group who also received invitation letters, but the coverage rate was still far from
universal among them.
Methods. Data from the 2010 edition of the Health Survey for England are used
(size of the estimation sample: 7,211). In order to partial out the e¤ect of unobservable
time costs, attitudes or access to vaccinations, immunisations against the seasonal and
pandemic inuenza are jointly estimated.
Results. Health risks, health behaviours and preferences, and exposure to various
information help explain the immunisation decision. Receiving the seasonal u vaccine
increases the probability of H1N1 vaccination uptake by 20 percentage points.
Conclusions. The widespread refusal of the vaccination can be worrying for the
control of potential future pandemics. Providing clear, well targeted information, en-
suring that high risk groups are contacted, and raising the level of health consciousness
can increase the coverage rate with vaccinations.
1 Introduction
In April 2009 the WHO announced the emergence of a novel inuenza A virus of the H1N1
strain. H1N1 vaccinations were available in England from late October 2009. Initially the
vaccination was available only to certain groups as specied by the NHS (National Health
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Service), who received invitation letters: pregnant women, people with diabetes, chronic
lung, heart, kidney, liver or neurological disease, and immunosuppression, people who lived
in the same house as someone whose immune system was compromised, and front-line health
or social care workers. At the same time, free seasonal vaccinations were also available to
people aged 65 and above.
There are recent international empirical results on the uptake of H1N1 vaccinations
(Bone et al. (2010), Maurer et al. (2010), Poland (2010), Bish et al. (2011), among others).
My study extends this literature by using a novel set of indicators of health preferences and
beliefs from a representative survey of the English population. The data make it possible
to analyse the actual vaccination uptake rather than only the intentions. I partial out the
inuence of some unobserved characteristics by a joint analysis of the pandemic and seasonal
vaccination uptake. The applied statistical methods are innovative compared to other stud-
ies that analyse the e¤ect of past seasonal u vaccination on the uptake of H1N1 vaccine
(Mauer et al. (2009), Eastwood et al. (2010), among others). The empirical strategy of this
paper is possible only because the pandemic and seasonal u vaccinations were available at
the same time. The objective is to estimate which demand-side factors had the strongest
inuence on the pandemic u vaccination uptake. Understanding the motivating factors of
vaccination uptake is important for the controlled spread of potential future epidemics.
2 Methods
2.1 Data
I use the 2010 edition of the Health Survey for England, an annually repeated cross sectional
study, representative for private households. I restrict the sample to respondents aged 18
and above, as from this age no parental consent is needed for the vaccination. I use weighted
data, with weights for analysis of the core interview sample.
The survey of 2010 asks if since October 2009 the respondent has received a u jab, and
the date and type of each vaccination. It is possible for respondents interviewed early in
2010 that the vaccination happened after the interview. This is a measurement error which
can increase the standard errors of the estimates.
I classify a respondent to the target group if has any of the following long-standing ill-
nesses: cancer, diabetes, heart attack or angina, kidney problems, bronchitis or emphysema.
Based on the survey the other categories of the target group cannot be identied precisely
enough.
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2.2 Statistical analyses
Specication (1) is a probit model of H1N1 jab uptake. The probit estimates are subject
to bias if the unobserved time cost of receiving the vaccination or the unobserved access
to or attitudes towards vaccinations are correlated with any of the included regressors. I
follow two approaches to handle this problem. Specication (2) is a bivariate probit model
of pandemic and seasonal u vaccinations, where the unobserved properties are captured by
the inclusion of the seasonal u uptake as a control variable in the equation of pandemic
vaccination. This specication takes into account the potential endogeneity of the seasonal
u vaccination, and the model is identied by functional form. In specication (3) I restrict
the estimation sample to respondents who received seasonal u vaccination, thus for whom
the marginal time cost of the additional H1N1 vaccination can be assumed to be zero and
accessibility is not an issue. The three specications are expected to give similar results only
if the inuencing role of the unobserved properties are negligible.
In all three specications I control for individual characteristics capturing health pref-
erences (age, gender, smoking, alcohol consumption, religion, being loved), access to the
vaccine (belonging to the target group, living in London), potential benets and opportu-
nity costs of the vaccinations (age, labour force status, belonging to the target group), or the
available information related to the vaccinations (education level, general interests, living
in London). I also include a binary indicator of age 65 and above, since above that age the
seasonal u vaccine is o¤ered for free.
3 Results
Descriptive statistics are presented in Table 1. The vaccination rate within the generated
target sample (40:7%) is higher than the o¢ cial statistics (37:6%, according to Pedoby and
Sethi (2010)).
The estimated average marginal e¤ects of the three probit models are reported in Table
2. Specication (1) shows correlations: the strongest results are that people living in London
are 5.4 percentage points less likely to receive H1N1 vaccination, whereas those belonging to
the target group are 14.6 percentage points more likely.
The results of specication (2) can be interpreted as causal e¤ects. The main di¤erence
from the results of specication (1) is that people aged 65 and above are 3 percentage
points less likely to receive the pandemic u vaccine, ceteris paribus. Feeling loved increases,
whereas general interests decrease the uptake of the H1N1 vaccine. Being an ex smoker has
1.9 percentage points positive e¤ect, living in London has 4.9 percentage points negative
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e¤ect. Belonging to the target group and receiving the seasonal u jab both have strong
positive e¤ect on the uptake of the pandemic vaccination.
The sign pattern of the results of specications (2) and (3) are similar, but the magnitude
of the estimated e¤ects are larger if the sample is restricted to those who received the seasonal
u jab. For example, the marginal e¤ect of living in London is 17.8 percentage points under
this specication.
4 Discussion
Conditional on receiving the seasonal u jab, people aged less than 65 are more likely to
receive the pandemic vaccination, suggesting high benets of or positive attitudes towards u
vaccinations. The positive e¤ect of having the seasonal u vaccine can be due to unobserved
positive attitudes towards immunisation, higher risks of falling ill with a u, and lower
marginal time cost of H1N1 vaccination once the seasonal u vaccine is received. The higher
probability of uptake among those who report being loved reects the higher subjective
benets of being vaccinated. The estimated e¤ect of general interests can capture exposure
to information related to the alleged risks of the vaccinations.
The nding that people living in London are signicantly less likely to receive the H1N1
vaccination is in line with the NHS (2010a) report. Previous explanations include problems in
the information system and the unique demographic and socio-economic composition of the
population of London (NHS (2010b)). However, since these results are stronger conditional
on receiving the seasonal u vaccine, it is more likely that beliefs and exposure to information
drive the London-e¤ect.
Being an ex smoker is related to the uptake of pandemic u vaccination potentially due
to health preferences (Hersch and Viscusi (1990), Hsieh and Lin (1997)).
The uptake rate of the H1N1 vaccination in England remained relatively low, which can
be worrying for the control of potential future pandemics. Plans-Rubió (2012) documents
that herd immunity in case of the H1N1 pandemic of 2009 could be achieved with 9-29% of
vaccination rate. However, much higher immunisation rates might be needed if the relative
number of secondary cases is higher. My results suggest that providing clear, well targeted
information on the risks and benets of the immunisation, and raising the level of health
consciousness can increase the coverage rate with vaccinations. The variations among those
who received the seasonal u vaccine indicate that better information provision at general
practices could have increased the uptake of the pandemic vaccine, and the low uptake rate
cannot be solely explained by lack of access or by general aversion against u vaccinations.
These implications are in line with the results of Maurer (2009) who documents the impor-
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tance of physician quality on seasonal u vaccination uptake.
As the results of this paper are based on the immunisation against a single u pandemic
in England, these can be relevant to but not fully representative for other countries or other,
potentially more severe epidemics.
5 Conclusions
The results of this paper indicate that even if the marginal time cost of receiving the pandemic
u vaccination is zero and general attitudes towards u vaccinations are controlled for, there
still remains individual heterogeneity in the likelihood of pandemic u vaccination uptake.
Health preferences, exposure to information, and subjective beliefs on the benets of the
vaccine all inuence the uptake probability. Clear, well targeted information, and raising
the level of health consciousness can increase the coverage rate with vaccinations.
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Table 1: Descriptive statistics, Health Survey for England 2010, weighted data restricted to
age 18+
Received
Whole sample Target sample seasonal u jab
N = 7,211 N = 742 N = 2,056
seasonal u jab, N (%) 1,803 (25.0) 497 (67.0)
swine u jab, N (%) 905 (12.6) 302 (40.7) 884 (43.0)
both u jabs, N (%) 775 (10.8) 281 (37.8) 884 (43.0)
age, mean (SD) 47.70 (18.09) 62.80 (14.57) 63.68 (16.42)
female, N (%) 3,705 (51.4) 350 (47.2) 1,106 (53.8)
employee, N (%) 3,618 (50.2) 183 (24.6) 539 (26.2)
self employed, N (%) 576 (8.0) 44 (5.9) 85 (4.1)
unemployed, N (%) 368 (5.1) 16 (2.1) 38 (1.8)
retired, N (%) 1,589 (22.0) 390 (52.5) 1,176 (57.2)
other inactive, N (%) 1,060 (14.7) 110 (14.8) 219 (10.7)
higher education or full time student, N (%) 2,830 (39.2) 204 (27.5) 581 (28.2)
have been feeling loved past 2 weeks 4 (2) 4 (2) 4 (2)
1:never - 5: all the time, median (IQR)
interested in new things past 2 weeks 4 (1) 3 (1) 4 (1)
1:never - 5: all the time, median (IQR)
current smoker, N (%) 1,432 (19.9) 121 (16.3) 238 (11.6)
ex regular smoker, N (%) 1,917 (26.6) 305 (41.1) 806 (39.2)
alcohol past 12 months 0: none - 4 (3) 3 (4) 4 (3)
- 7: almost every day, median (IQR)
not religious, N (%) 1,851 (25.7) 120 (16.2) 293 (14.3)
religion - Christian, N (%) 4,866 (67.5) 585 (78.8) 1,664 (80.9)
other religion, N (%) 494 (6.9) 37 (5.0) 99 (4.8)
London, N (%) 967 (13.4) 94 (12.7) 224 (10.9)
heart problems, N (%) 111 (1.5) 126 (16.9) 88 (4.3)
diabetes, N (%) 345 (4.8) 392 (52.8) 289 (14.1)
cancer, N (%) 169 (2.3) 191 (25.8) 114 (5.6)
lung disease, N (%) 44 (0.6) 50 (6.7) 37 (1.8)
kidney disease, N (%) 56 (0.8) 63 (8.6) 32 (1.5)
in target group, N (%) 654 (9.1) 500 (24.3)
SD = standard deviation, IQR = interquartile range
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Table 2: Estimated average marginal e¤ects on H1N1 vaccination uptake probability in
percentage points, Health Survey for England 2010, weighted data restricted to age 18+
(1) (2) (3)
Probit, conditional on
Probit Bivariate probit seasonal vaccination
age 0.21 (0.14,0.28) 0.03 (-0.04, 0.10) -0.09 (-0.36, 0.18)
age  65 2.09 (-0.73, 4.91) -2.99 (-5.97, -0.01) -15.58 (-23.92, -7.25)
female 1.66 (0.16, 3.17) 1.50 (0.18, 2.82) -1.70 (-6.41, 3.02)
self employed -2.77 (-5.88, 0.35) -1.02 (-3.73, 1.69) 7.95 (-4.37, 20.26)
unemployed -2.22 (-6.50, 2.07) -2.13 (-6.06, 1.81) -6.82 (-24.07, 10.43)
retired 2.08 (-0.61, 4.77) 0.67 (-1.67, 3.01) 2.31 (-5.89, 10.51)
other inactive -0.20 (-2.50, 2.11) -1.41 (-3.54, 0.71) -3.18 (-11.84, 5.48)
higher education 1.16 (-0.44, 2.76) 1.21 (-0.20, 2.62) -0.59 (-5.95, 4.77)
loved (1-5) 1.43 (0.59, 2.27) 1.09 (0.37, 1.81) 2.16 (-0.38, 4.70)
interests (1-5) -1.16 (-1.96, -0.36) -0.84 (-1.52, -0.17) -2.66 (-4.99, -0.33)
smoker -2.65 (-4.81, -0.48) -1.62 (-3.63, 0.39) -6.42 (-14.23, 1.39)
ex smoker 2.83 (1.24, 4.42) 1.90 (0.51, 3.28) 4.45 (-0.30, 9.19)
alcohol (0-7) -0.19 (-0.55, 0.17) -0.20 (-0.50, 0.11) -0.84 (-1.88, 0.19)
Christian 1.55 (-0.36, 3.47) 0.36 (-1.35, 2.06) 1.86 (-4.94, 8.65)
other religion 2.48 (-1.22, 6.18) 0.23 (-3.27, 3.73) -3.56 (-17.20, 10.08)
London -5.42 (-8.17, -2.66) -4.87 (-7.39, -2.34) -17.77 (-26.29, -9.25)
target group 14.57 (12.58, 16.55) 8.45 (6.43, 10.47) 16.65 (11.78, 21.52)
seasonal vaccination 19.67 (14.48, 24.86)
sample size 7,211 7,211 2,056
pseudo R2 0.13 0.05
correlation of the error terms 0.21 (0.01, 0.41)
95% condence interval in parentheses, signicant at 10%;  signicant at 5%;  signicant at 1%
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